How many employees does Neurocrine Biosciences, Inc. have?

Neurocrine Biosciences, Inc. reported 2,000 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 11, 2026. That is up 11.1% from a year earlier.

What is Neurocrine Biosciences, Inc.'s revenue per employee?

Neurocrine Biosciences, Inc. brought in $2.86B of revenue in fiscal Dec 2025, which is $1.43M per employee. That ranks 10 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Neurocrine Biosciences, Inc. employees and revenue per employee

NBIX · Biotechnology · $14.4B market cap

Neurocrine Biosciences, Inc. had 2,000 employees at the end of fiscal Dec 2025, up 11.1% from a year earlier. Revenue for the year was $2.86B, up 21.4% from a year earlier, or $1.43M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

2,000

+11.1% YoY

Revenue

$2.86B

+21.4% YoY

Revenue / employee

$1.43M

Peer median $602K

Rank in industry

10 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

NBIX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	2,000	$2.86B	$1.43M	+11.1%	+21.4%
Dec 2024	1,800	$2.36B	$1.31M	+28.6%	+24.8%
Dec 2023	1,400	$1.89B	$1.35M	+16.7%	+26.8%
Dec 2022	1,200	$1.49B	$1.24M	+33.3%	+31.3%
Dec 2021	900	$1.13B	$1.26M	+6.5%	+8.4%
Dec 2020	845	$1.05B	$1.24M	+20.7%	+32.7%
Dec 2019	700	$788M	$1.13M	+19.7%	+74.7%
Dec 2018	585	$451M	$771K	+46.2%	+179.2%
Dec 2017	400	$162M	$404K	+104.1%	+977.5%
Dec 2016	196	$15.0M	$77K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Neurocrine Biosciences, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
UTHR United Therapeutics Corporation	1,400	$3.18B	$2.27M	Efficient growth
EXEL Exelixis, Inc.	1,077	$2.32B	$2.15M	Leaner
INCY Incyte Corporation	2,844	$5.14B	$1.81M	Efficient growth
PTCT PTC Therapeutics, Inc.	991	$1.73B	$1.75M	Efficient growth
ALNY Alnylam Pharmaceuticals, Inc.	2,500	$3.71B	$1.49M	Efficient growth
NBIX Neurocrine Biosciences, Inc.	2,000	$2.86B	$1.43M	Efficient growth
BMRN BioMarin Pharmaceutical Inc.	3,221	$3.22B	$1.00M	Efficient growth
MRNA Moderna, Inc.	4,700	$1.94B	$414K	Contracting
FTRE Fortrea Holdings Inc.	14,300	$2.72B	$190K	Leaner

Every Healthcare company

Questions about Neurocrine Biosciences, Inc.

How many employees does Neurocrine Biosciences, Inc. have?: Neurocrine Biosciences, Inc. reported 2,000 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 11, 2026. That is up 11.1% from a year earlier.
What is Neurocrine Biosciences, Inc.'s revenue per employee?: Neurocrine Biosciences, Inc. brought in $2.86B of revenue in fiscal Dec 2025, which is $1.43M per employee. That ranks 10 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare NBIX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Neurocrine Biosciences, Inc.'s annual reports (Form 10-K), latest filed February 11, 2026. This is data, not a recommendation to buy or sell NBIX.